Obstetrics & Gynecology · Macon, GA
NPI
1164721130
Since 2011
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
764 Pine St
Macon, GA, 31201
Phone (478) 633-1056
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
194 services
Medicare patients, 2024
53
Average age 69
Drug cost, 2024
$142K
1,591 prescriptions
Company payments, 2025
$634
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Byron A Brooks Jr. was code 99214 (office e&m - established), 32 times for 20 patients. In total Byron A Brooks Jr. billed 194 services in 27 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 32 | 20 | $86.42 | $2,765 |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 30 | 30 | $17.69 | $531 |
| 99213 Office E&M - Established | Office | 27 | 20 | $59.89 | $1,617 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 24 | 24 | $36.14 | $867 |
| 81000 Clinical Chemistry | Office | 17 | 12 | $3.94 | $66.98 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 13 | 13 | $39.88 | $518 |
By year: 2022 $10K for 223 services; 2023 $7,674 for 197 services; 2024 $11K for 194 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 30 | 30 | $17.69 | $531 |
| 81000 Clinical Chemistry | 17 | 12 | $3.94 | $66.98 |
Medicare prescription drug claims, 2024
In 2024, the drug Byron A Brooks Jr. prescribed most often to Medicare patients was Estradiol, with 330 prescriptions and refills. In total Byron A Brooks Jr. wrote 1,591 Medicare prescriptions that cost $142K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 330 | 772 | 120 | $10K |
| Estradiol (Twice Weekly) Estradiol | 62 | 115 | 15 | $5,927 |
| Alendronate Sodium Generic | 58 | 114 | 11 | $318 |
| Premarin Estrogens, Conjugated | 58 | 145 | 24 | $31K |
| Ibandronate Sodium Generic | 57 | 162 | 22 | $1,802 |
| Myrbetriq Mirabegron | 45 | 72 | Under 11 | $33K |
| Fluconazole Generic | 44 | 44 | 31 | $205 |
| Escitalopram Oxalate Generic | 40 | 112 | 13 | $518 |
| Bupropion Xl Bupropion Hcl | 39 | 83 | 13 | $1,111 |
| Nystatin Generic | 37 | 39 | 27 | $280 |
| Levothyroxine Sodium Generic | 37 | 75 | Under 11 | $437 |
| Medroxyprogesterone Acetate Generic | 36 | 99 | 15 | $577 |
| Alprazolam Generic | 27 | 27 | Under 11 | $68.97 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 26 | 26 | 23 | $263 |
| Valacyclovir Valacyclovir Hcl | 26 | 48 | 15 | $1,539 |
Brand drugs: 233 claims; generic drugs: 1,358 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Byron A Brooks Jr. $634 ($634 in general payments such as food, travel and fees) from 11 companies. The largest payer was Astellas Pharma US Inc with $161.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 8 | $161 |
| Abbvie Inc. ABBV | 5 | $124 |
| Biogen, Inc. BIIB | 3 | $75.06 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $71.62 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $51.67 |
| Exeltis, USA Inc. | 2 | $42.13 |
| Mayne Pharma Commercial LLC | 2 | $39.19 |
| Pfizer Inc. PFE | 1 | $23.04 |
| Exact Sciences Corporation EXAS | 1 | $18.9 |
| OptumHealth Care Solutions, LLC | 1 | $18.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.